Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ADIAL PHARMACEUTICALS, INC. (ADIL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-KS-1S-1/A
Research and development expenses  8.45.94.00.40.2146,143.0322,107.0
General and administrative expenses  9.35.14.36.60.8264,664.0497,150.0
    Total Operating Expenses  39.010.98.215.51.0410,807.0819,257.0
    Loss From Operations  -19.3-10.9-8.2-7.0-1.0-410,807.0-819,257.0
Interest income  0.00.00.10.00.0240.01,264.0
    Total other income (expense)  -0.20.0-0.3-4.6-0.1  
Income (Loss) Before Provision For Income Taxes  -19.5-10.9-8.6-11.6-1.1  
   
Provision for income taxes         
    Net Income (Loss)  -19.4-10.9-8.6-11.6-1.1-420,200.0-817,993.0
   
Net income (loss) per share, basic and diluted (in Dollars per share)  ($1.05)($0.87)($0.87)($2.44)($0.35)($0.13) 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy